Skip to main content
PMC home page
Nature Communications logoLink to Nature Communications
. 2016 Sep 28;7:12971. doi: 10.1038/ncomms12971

Forward design of a complex enzyme cascade reaction

Christoph Hold 1, Sonja Billerbeck 1,*, Sven Panke 1,a
PMCID: PMC5052792  PMID: 27677244

Abstract

Enzymatic reaction networks are unique in that one can operate a large number of reactions under the same set of conditions concomitantly in one pot, but the nonlinear kinetics of the enzymes and the resulting system complexity have so far defeated rational design processes for the construction of such complex cascade reactions. Here we demonstrate the forward design of an in vitro 10-membered system using enzymes from highly regulated biological processes such as glycolysis. For this, we adapt the characterization of the biochemical system to the needs of classical engineering systems theory: we combine online mass spectrometry and continuous system operation to apply standard system theory input functions and to use the detailed dynamic system responses to parameterize a model of sufficient quality for forward design. This allows the facile optimization of a 10-enzyme cascade reaction for fine chemical production purposes.

Inline graphicBuilding multi-component enzymatic processes in one pot is challenged by the inherent complexity of each biochemical system. Here, the authors use online mass spectroscopy and engineering systems theory to achieve forward design of a ten-membered reaction cascade.

The ability to simultaneously operate reaction networks in one pot is highly attractive as large modifications of molecular structure or perfect optical purity can be achieved in one processing step, including reactions that in isolation would be thermodynamically unfavourable. With increasing network complexity, this ability becomes more and more exclusive to the biochemical reaction domain, as only nature has provided a huge set of catalysts that operate under similar conditions. Correspondingly, many such networks are operated in cells1,2,3,4. However, while acquiring enzymes remains laborious (but can be much facilitated by exploiting thermostable enzymes5,6,7,8), cell-free reaction networks or ‘cascade reactions' offer the advantage of the absence of membrane-induced mass transfer and many toxicity effects, facilitated use of non-natural compounds, use of not (exclusively) aqueous solvents, increased flexibility in network structure6,9 and better control of the reaction10,11,12,13,14. Consequently, such cell-free reaction networks or cascade reactions have been broadly distributed for a variety of purposes, including the synthesis of (activated) mono- and oligosaccharides15,16,17,18,19, various fine chemicals14,20,21,22,23,24,25,26, monomers8,27,28, polymers29,30,31,32, fuels6,7,33, hydrogen34,35 and the generation of electricity36,37.

However, increasing complexity often leads to non-optimal behaviour as the interactions remain poorly understood, and therefore the systems remain difficult to scale. First attempts at a semi-rational system optimization have been undertaken21,38, but a design process is best supported by a full system model that is well enough parameterized to reflect the main aspects of the behaviour of the cascade reaction. However, enzymes are subject to nonlinear kinetics, such as Michaelis–Menten-type kinetics, which is often complicated by feedback, cooperative or allosteric elements. This makes the development and in particular the robust parameterization of a suitable model a challenge, as standard experiments are not sufficient to resolve the many instances of non-identifiability that can accompany the parameterization efforts. Therefore, the forward design and implementation of synthetic biochemical pathways has not been demonstrated yet.

Interestingly, because of the importance of kinetics for understanding intracellular metabolism, most efforts towards the establishment of models for large enzyme reaction networks were undertaken for in vivo systems39,40, which represents an even more challenging system because of the additional mass-transfer barriers ((intra)cellular membranes) and the variable composition of the reaction system (cellular response to environmental stimuli). Consequently, though dynamic models exist for sections of central carbon metabolism in vivo, they are of limited use for forward engineering since during their development it was not possible to perform sufficiently dynamic experiments, such as applying diverse (intracellular) perturbations with different compounds and measuring a sufficient number of compounds. But even in cell-free systems, such as in vitro oscillators41,42,43,44, but also cascade reactions45, model development does not go beyond the estimation of a few parameters, and thus leaves the complexity of the system unresolved and thus design uncertain.

We reasoned that in vitro forward design would become possible if the experimental system allowed a sufficiently broad application of dynamic challenges and a sufficiently detailed recording of the system's responses. We therefore explored the construction of a highly versatile experimental set-up that allows the generation of standard input functions from systems theory applied to a continuous stirred tank reactor (CSTR) and the collection of sufficiently detailed concentration time series from the system's response with a recently developed real-time mass spectrometry method38. While a CSTR would not be a suitable reactor for large-scale implementation of a multi-step reaction, we reasoned that the set-up would in fact remove the central obstacle for forward engineering of complex reaction systems, namely limited model scope due to insufficient experimental data quantity and quality, and thus enable generating a model for design. We demonstrate this by successfully forward engineering a 10-enzyme cascade reaction to produce an important intermediate in enzyme-catalysed monosaccharide synthesis, dihydroxyacetone phosphate (DHAP)46.

Results

Tracking complex system perturbations with high data density

Implementation and analyses of the reaction system were performed in a CSTR (Fig. 1a)47, which is indispensable for a thorough engineering analysis of the system. The composition of the feed into the reactor and the dynamics of its change were set by controlling multiple feed high-performance liquid chromatography (HPLC) pumps and an injector loop. This allows freely impressing diverse concentration feed profiles, representing different standard input functions, onto the reaction system (Fig. 1b). To record the dynamics of the response of the reaction system to the input functions, the constant product stream is removed through an ultrafiltration membrane, which retains the enzymes (thus stopping the reactions) but lets pass the liquid with remaining starting materials, intermediates and products. This continuous reactor effluent is conditioned with MS matrix buffer for subsequent online measurement in an electrospray ionization (ESI) MS (Supplementary Table 2), which is operated in multi-reaction monitoring mode and allows the determination of the concentration of one compound every 500 ms (ref. 38). Consequently, even reaction systems can be easily tracked, allowing systems in the order of 20 compounds to be analysed in ∼20 s (including standards). To separate the dynamics of the system from contributions of the set-up, we thoroughly identified the transfer function of the experimental set-up in step-wise fashion (Fig. 1c and Supplementary Fig. 1) and found that the influence of the set-up can be accurately described as a coupled system of three CSTR's describing pump, reactor and post-reactor dilution elements.

Figure 1. Experimental strategy for system identification.

Figure 1

Open in a new tab

(a) Set-up of function generation unit consisting of one or multiple HPLC pumps, injection loop and/or syringe port, enzymatic reaction consisting of a CSTR with membrane for enzyme retention, sample preparation to condition continuous reactor effluent for MS injection and online measurement in a ESI-triple-quad MS. (b) Possible input functions with theoretical form, practical realization of the function and measured system response at the outlet of the CSTR, and idealized substrate profile in CSTR without (green stippled line) and with (red solid line) enzyme reaction system. (c) Stepwise full identification of the dynamics of the set-up. Model: schematic representation of the stepwise identification process. Each line represents a schematic of the specific set-up used for identification of the specific element (known elements in grey, element to be identified in green). Once identified, a system element was modelled as indicated in the subsequent identification steps. Experiment: result of the particular identification with the representation of the generated perturbation in magenta and the system response in normalized concentration as simulated (green, using the values indicated in ‘Model') and measured (blue).

Next to this identification of the set-up, we ensure accurate measurement of compound concentrations despite the potential for ion suppression due to the concomitant entry of many compounds into the ESI chamber of the MS. We use chemically orthogonal standards to measure the ratio of the flows from effluent and conditioning and then either isotopologues or an orthogonal standard with extensive calibrations to calculate compound concentrations (Supplementary Fig. 2). This set-up can be used for a broad variety of cascade reactions involving at least 40 compounds, or multiples of this number if the effluent is split and directed to different mass spectrometers. We also ensured sufficient enzyme stability for our specific reaction system (Supplementary Fig. 3).

Enabling structural model identification

As a first test with still limited scope we tested the set-up's capacity for structural model identification. Interestingly, the reaction mechanism of a variety of glucokinases (Glk's, for abbreviations of enzyme and compound names see Supplementary Table 1), such as that of the yeast Saccharomyces cerevisiae48, is described to include an inhibition term for ADP, while the mechanism for the enzyme of Escherichia coli that was used in the present experiments (Supplementary Table 3), does not (Supplementary Note 1 and Supplementary Table 24). Therefore, we impressed different input functions representing very different substrate concentration dynamics onto the reactor containing only Glk and used the recorded dynamic responses to estimate the parameters when the inhibition term was not included (Fig. 2a and Supplementary Fig. 4). Clearly, despite the limited number of parameters the selected optimizer cannot identify a suitably small range of parameter values for the affinities for Glc and ATP, even when the impressed substrate profiles become complex. This suggests non-identifiability due to the assumption of a wrong model. Including the ADP-inhibition term allows estimating a suitable parameter set (Fig. 2a, bottom panel), but only after the input function has become complex enough to resolve structural non-identifiability due to too simple feed profiles.

Figure 2. Model identification.

Figure 2

Open in a new tab

(a) Structural identification of the reaction mechanism of Glk. Displayed is on the top a schematic of the type of experiment used for identification. The data were used to estimate the parameters of two different rate equations for Glk, once excluding (red symbols) and once including (green symbols) a term for ADP inhibition. We carried out for each model 100 independent parameter estimation runs and show the obtained s.d.'s for the parameter estimation, which suggest the requirement for an ADP inhibition term. (b) Enzymatic cascade reaction for the production of DHAP. Note the simulated consumption reaction for DHAP by G3d-catalysed conversion to G3P. Stippled arrows: enzyme activation. Blunt stippled lines: enzyme inhibition (c, competitive; a, allosteric). Stippled boxes: isomers whose concentrations were measured as pool. Abbreviations from Supplementary Table 1. (c) Typical parameter estimation experiment from the lower part of glycolysis (experiment E3 of Supplementary Table 12). Upper panel: summary of starting conditions and interventions during experiment. Units refer to the absolute amount of enzyme added at a given time, concentrations to expected concentration changes. Lower panel: blue, measured concentrations; green, simulation. (d) Affinity parameters with best estimate as blue star, estimation boundaries (green) and range of parameters mentioned in the literature (red).

Assembly of a model cascade reaction

Next, we implemented a multi-step reaction system from purified enzymes (mostly commercial and from different hosts, Supplementary Table 3) to produce DHAP from glucose (GLC) as shown in Fig. 2b. The system contains 10 enzymes and 17 compounds, and is thus in terms of size at the upper end of cascade reactions that are intended for cell-free chemical production6,35. We chose this pathway because, first, it generates an essential precursor for enantioflexible synthetic routes (DHAP can be converted into a stereochemically complete set of vicinal diols46); second, DHAP synthesis and cofactor regeneration can be achieved by building essentially on glycolytic enzymes, whose mechanisms are sufficiently well known to develop a mechanistic dynamic model, but their interactions are complex because of multiple regulatory feedback loops; and third the need for ATP and NAD recycling in the pathway reflects that the thermodynamic profiles of cascade reactions are rarely monotone and activation by cofactors is often necessary. We also expanded this network by an additional reaction, reduction of DHAP by glycerol 3-phosphate dehydrogenase (G3d) to glycerol 3-phosphate (G3P) as a model product. This reflects that DHAP is rather an essential precursor than a final product18. As the G3d reaction regenerates NAD, lactate dehydrogenase (Ldh) can be omitted in those cases.

Model formulation and parameterization

We translated this reaction system into a model. By balancing the 18 compounds in the previously identified 3-vessel system (Fig. 1c), an overall model with 54 states describing the generation of input profiles and concentration propagation through the system was derived. We also derived 11 mechanistic enzyme rate laws for the enzymes of the reaction system based on literature-described reaction models (Supplementary Note 1 and Supplementary Table 24) with 60 parameters, such as affinities and Hill coefficients. The values of these parameters were not known a priori and depend on the specific enzyme and reaction conditions such as pH, buffer composition, temperature or ionic strength; even reported values for some of the enzyme parameters vary by orders of magnitude. We therefore estimated these parameters by dividing the system into manageable subsystems of up to 4 enzymes and maximally 24 parameters (Supplementary Fig. 5).

For each subsystem, we conducted different types of perturbation experiments ranging from pulsing enzymes via a constant feed to substrate gradients, resulting in a total of 22 experiments of the type shown in Fig. 2c (Supplementary Figs 6–11 and Supplementary Tables 4–17). While simulations of concentration time series of separate subsystems using parameters that were derived from the experiments specific for this subsystem are generally in excellent agreement with the data (Fig. 2c), the quality of the simulations of groups of subsystems with such parameters is often less satisfactory. Therefore, some of the subsystems required re-estimation of some enzyme parameters multiple times. Ultimately, the set of 22 experiments allowed estimating a final set of parameters (Supplementary Table 18 and Fig. 2d) that reproduced all experiments well as the basis for the subsequent design phase. Only few parameters (for example, for Pfk) are at the boundary of the allowed range, suggesting cases of limited identifiability that might have been resolved with additional experiments. Next, consultation of suitable databases (in particular BRENDA49) allowed comparing 32 of the 36 compound affinities, whose knowledge we had deemed most uncertain before, with previously known values. Of these 32 affinities, 24 are within generally reported ranges (Fig. 2d). Possible reasons include that our reaction conditions might have been different from those under which these parameters had been previously established (in particular, presence of a broad variety of compounds). However, we refrained from further refining the perturbations and the parameter set as the models for the subsystems, as well as the complete model are already fully capable of enabling forward design.

Optimizing a cascade reaction for product concentration

To demonstrate this, we optimized different aspects of the reaction cascade, specifically enzyme use in the upper and in the lower part of the cascade separately, as well as in the cascade as a whole, and, finally, the use of the most expensive cofactor in the system, NAD. For the optimization of enzyme use, this meant identifying the optimal distribution of a given total amount of enzyme over the different reaction steps. Please note that, fundamentally, such a cascade would ideally be run in a batch or fed-batch reactor to prevent loss of intermediates (and thus a reduction in yield on GLC). However, to maintain the ability to track the behaviour of the optimized system accurately and at high time resolution, we remained in the CSTR setting, which is anyway close to a batch scenario as the dilution rate is rather low (2.1 h−1). We started with the upper part of the cascade (from GLC to fructosebisphosphate (FBP)) and compared the scenario in which each of the three enzymes was available with the same activity (‘equi-activity scenario', total enzyme amount 3 U) to the model-predicted optimal distribution (Fig. 3a and Supplementary Table 19). Clearly, prediction and experiment for the optimized scenario are in good agreement, and FBP concentration in the effluent is increased by 26%, even though the GLC consumption remains nearly constant. Next, we optimized the lower part of the cascade (starting with FBP, total of 7 U, Supplementary Table 20) for G3P and pyruvate (PYR) production, again in comparison with the equi-activity scenario. Again, prediction and experiment show good agreement in dynamics and steady-state concentrations and a large increase in G3P concentration in the effluent by 75% (Fig. 3b). Finally, we optimized the entire cascade (GLC to G3P and PYR) with different total amounts of enzymes to be optimally distributed (20 and 40 U). This allows, in good agreement with the predictions, a steady increase in GLC consumption and G3P and PYR production (for example, 88% increase of G3P steady-state concentration in the 20 U scenario) (Fig. 3c and Supplementary Table 21).

Figure 3. System optimization.

Figure 3

Open in a new tab

(a) Performance of equi-activity (reference, only predicted) and optimized (predicted and measured) upper part of reaction system. (b) Performance of equi-activity and optimized lower part of reaction system. (c) Performance of complete reaction system after distribution of either 20 or 40 U of enzymes, either in equi-activity or in optimized distribution. (d) Performance of complete reaction system (total of 10 U) with 0.25 or 1 mM NAD in the feed. All experiments were conducted with constant feed and started by injection of the respective enzyme system. E, experiment; O, optimization; R, reference; S, simulation.

Optimizing a cascade reaction for cofactor concentration

Next to productivity, cofactor costs are a major impediment to the implementations of cascade reactions. Consequently, we analysed how far the NAD concentration could be reduced without reducing the G3P productivity shown in Fig. 3c. We conducted in silico experiments with the NAD concentration changing in steps from 0.1 to 2 mM (Supplementary Fig. 12), and found that an NAD concentration of 0.25 mM, only one-fourth of the previously used concentration, is predicted to be sufficient for comparable product formation (Supplementary Table 22). When the corresponding experiment at reduced NAD concentration is implemented, G3P productivity is indeed hardly affected (Fig. 3d).

In summary, we demonstrate the non-iterative model-based forward design and implementation of one of the most complex in vitro enzymatic reaction systems ever implemented for chemical production. Clearly, forward design is possible even in highly feedback-controlled systems such as those built on glycolytic enzymes, if only sufficient data of sufficient information content can be provided, which we did in the presented set of experiments. While, strictly speaking, we show this only for the case of the continuous reaction, the obtained model can of course also be used to design batch reaction. The applied set-up allows for full control and observation of experiments, and the presented methods are scalable and allow for the construction and measurement of even more complex reaction systems for applications in fine and bulk chemical processes. Some aspects of this work will also be useful for experiments in the in vivo domain. Even though we used here enzymes from different hosts and in purified form (eliminating potentially unknown interactions with additional effectors and competing substrates that would be available in a cell, as well as possible effects of protein complexes and intermediate and/or product sinks), the presented model has been shown to capture the system behaviour rather accurately and might thus serve as a qualitative tool for supporting the analysis of intracellular dynamics of glycolysis.

Methods

Source of enzymes

All enzymes except Glk were obtained as summarized in Supplementary Table 3. For reactor experiments the catalytic unit definition as provided by the supplier and as detailed in Supplementary Table 3 was used. Glk was produced as a His6-tagged variant recombinantly in an E. coli BL21 strain from a gene under the control of the phage T7-promoter on pBR322-type plasmid and affinity purified. For more detailed description see Supplementary Methods.

Set-up of experimental system

Perturbation functions were generated by combining a (multi-channel) HPLC pump and an injection loop, connected through polyether ether ketone capillaries to the main reactor. Supplying defined compound concentrations in the reaction buffer from the HPLC pump established a continuous reaction feed; switching abruptly from one to a second reaction buffer allowed implementing step functions. Switching gradually over time allowed implementing a ramp function and even more complex input functions such as a sine could be realized by programming the pump. Using the injector for compounds allowed approximating an impulse by producing a pulse from an injector loop volume small in relation to the flux provided by the pump. Finally, using it for enzyme supply produced a step function in terms of reactor enzyme concentration. The enzyme membrane reactor (Bioengineering AG, Wald, Switzerland) was constantly stirred (600 r.p.m.) and featured a cellulose triacetate membrane with a cutoff at 20 kDa. The reactor effluent was conditioned for subsequent online MS detection by diluting it between 30- and 100-fold with the MS matrix buffer. Afterwards, the flow was split to limit influx into the MS. The exact fluxes were calculated from standard compounds (see below). For more detailed description see Supplementary Methods.

Mass spectrometry

A triple quadrupole mass spectrometer (MS) (MDS Sciex 4000 Q-TRAP, Applied Biosystems, CA, USA) with ESI was used in multiple reaction monitoring setting and in negative-ion mode. The applied routines (Supplementary Methods) did not allow resolving structural isomers, specifically the pairs G6P/F6P, 2PG/3PG and DHAP/GAP. These were measured in three pools: X6P (for G6P/F6P); XPG (for 2PG/3PG); and XAP (DHAP/GAP).

Identification of experimental system

The experimental system was decomposed into subunits, which were identified one after the other using 1 mM GLC in reaction buffer to generate perturbations recorded by the MS. Neglecting the set-up-specific dead times, the injector response was close to an ideal step. The other system elements generally behaved as first-order lag elements with dead time and were fitted to a CSTR model. For more detailed description including estimated volumes see Supplementary Methods.

Compound quantification

To measure accurate concentrations despite ion suppression effects and irregularities in flow through capillaries, we used three different procedures: the flux was monitored by adding different isotopologues of taurine to reaction and MS-matrix buffer, and ion suppression was accounted for by either adding isotopologues of starting materials, intermediates and products to the MS-matrix buffer to serve as a known reference measured under identical ESI conditions or through extensive calibration against HEPES as another standard in the MS-matrix buffer. For a detailed treatment of compound quantification see Supplementary Methods.

Enzyme stability

Enzyme stability was confirmed indirectly from the stability of steady-state signals for the various starting materials, intermediates and substrates in the CSTR during specific experiments. See Supplementary Methods for more details.

General computational methods and kinetic model

All computations were performed with Matlab (Mathworks, MA, USA). For efficient simulation the kinetic model was coded in C and compiled by the SBPD extension package of the Systems Biology Toolbox 2 (ref. 50) together with the CVODE integrator51 as a Matlab-callable MEX function. This allowed for a, in comparison with Matlab, very fast model integration with up to 2.5e8 simulations of the kinetic model per day on a 12 core server system, assuming the least complex constant feed experiment with a single initial enzyme injection and 60 min simulation time. Thermodynamic data were calculated using eQuilibrator 1.0 (ref. 52). The kinetic model was constructed by balancing the compounds, formulating rate laws for the enzymes and embedding them into the identified three-vessel system of the experimental set-up. The kinetic model describes the reaction network on the basis of 54 ordinary differential equations derived by balancing the metabolite fluxes within the reactor. Rate equations were derived based on literature information considering known mechanism, sequence of metabolite binding and effectors. Reactions were modelled as irreversible if the calculated thermodynamic equilibria were more than 1,000-fold on the product side. Special care was taken to include regulatory properties of the pathway members, such as allosteric effects, competitive inhibitions and cooperativity. For detailed information on equilibria and the model itself see Supplementary Methods.

Optimization of fit

To search the parameter space for parameter estimation and optimizing enzyme concentrations a Gaussian adaptation algorithm53 served as optimizer. The used algorithm is a probabilistic method resulting in different outcomes for different optimization runs and so by default multiple runs were performed to ensure optimal results. For the estimation of parameter p, the mean squared error function between measurement and simulation was minimized as a quality criterion. For more details, see Supplementary Methods.

Data processing

The practical implementation of the compound quantification strategies required a standardized workflow to deal with the imperfection of real data, consisting of first, elimination of crosstalk in raw data; second, calculation of metabolite concentrations; third, correction of calculated concentrations by matching of observed and set concentrations; fourth, calculation of ideal and real mass balances; and finally corrections of calculated concentrations by matching with the ideal balances. The elaborate treatment of these steps is detailed in Supplementary Methods and Supplementary Fig. 13.

Parameterization

For the initial parameterization of the reaction model and the definition of parameter boundaries for the parameter estimation we used different sources. Vmax values were obtained from the known amount of added enzymes, equilibrium constants were calculated from thermodynamic data (eQuilibrator 1.0; ref. 52) as in Supplementary Table 23 and intrinsic enzymatic properties such as enzyme affinities (KM values) were obtained from databases such as BRENDA49 and literature research. Then, improved estimates for the affinity parameters, thermodynamic equilibria and Hill coefficients were obtained by varying initial values and comparing simulated and experimental data and minimizing the difference. Where specific reactions could not be resolved (see pools above), affinities from literature were maintained. For detailed information on parameterization, see Supplementary Methods.

System optimization

The optimization of the reaction system was performed by adapting the activity of single enzymes for a given total amount of activity with regards to one- or two-compound concentrations. For this the optimizer suggested an activity distribution and simulated the experimental outcome of a constant feed experiment with initial enzyme injection for a chosen experimental length. The finally reached concentration at steady state was taken as criterion and provided to the optimizer that then suggested another distribution. For more detailed information see Supplementary Methods.

Data availability

Data supporting the findings of this study are available within the article (and its supplementary information files) and from the corresponding author on reasonable request. Also, the MATLAB model and all concentration data are available in the ETH Data Archive with the identifier IE2151530 (ref. 54).

Additional information

How to cite this article: Hold, C. et al. Forward design of a complex enzyme cascade reaction. Nat. Commun. 7, 12971 doi: 10.1038/ncomms12971 (2016).

Supplementary Material

Supplementary Information

Supplementary Figures 1-13, Supplementary Tables 1-24, Supplementary Note 1, Supplementary Methods and Supplementary References.

ncomms12971-s1.pdf (2.5MB, pdf)
Peer Review File
ncomms12971-s2.pdf (285.2KB, pdf)

Acknowledgments

We thank Joerg Stelling for critical reading of the manuscript; Anne Femmer who provided assistance in many of the reactor experiments and the Glk production; and Hiroki Kawahara for the construction of the glk expression plasmid. We acknowledge financial support from The European Union (Projects EuroBioSyn (#12749), Nanomot (#29084) and ST-FLOW (#289326)), and the ESF-sponsored project Nanocell.

Footnotes

Author contributions C.H., S.B. and S.P. conceived the experiments; C.H. and S.B. performed the experiments; C.H. analysed the data; C.H. and S.P. co-wrote the paper.

References

  1. Lee J. W. et al. Systems metabolic engineering of microorganisms for natural and non-natural chemicals. Nat. Chem. Biol. 8, 536–546 (2012). [DOI] [PubMed] [Google Scholar]
  2. Keasling J. D. Manufacturing molecules through metabolic engineering. Science 330, 1355–1358 (2010). [DOI] [PubMed] [Google Scholar]
  3. Woolston B. M., Edgar S. & Stephanopoulos G. Metabolic engineering: past and future. Ann. Rev. Chem. Biomol. Eng. 4, 259–288 (2013). [DOI] [PubMed] [Google Scholar]
  4. Chen Y. & Nielsen J. Advances in metabolic pathway and strain engineering paving the way for sustainable production of chemical building blocks. Curr. Opin. Biotechnol. 24, 965–972 (2013). [DOI] [PubMed] [Google Scholar]
  5. Zhang Y.-H. P., Sun J. & Zhong J.-J. Biofuel production by in vitro synthetic enzymatic pathway biotransformation. Curr. Opin. Biotechnol. 21, 663–669 (2010). [DOI] [PubMed] [Google Scholar]
  6. Guterl J.-K. et al. Cell-free metabolic engineering: production of chemicals by minimized reaction cascades. ChemSusChem 5, 2165–2172 (2012). [DOI] [PubMed] [Google Scholar]
  7. Krutsakorn B. et al. In vitro production of n-butanol from glucose. Metabol. Eng. 20, 84–91 (2013). [DOI] [PubMed] [Google Scholar]
  8. Ye X. et al. Synthetic metabolic engineering-a novel, simple technology for designing a chimeric metabolic pathway. Microb. Cell Fact. 11, 120 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bogorad I. W., Lin T.-S. & Liao J. C. Synthetic non-oxidative glycolysis enables complete carbon conservation. Nature 502, 693–697 (2013). [DOI] [PubMed] [Google Scholar]
  10. Guterl J.-K. & Sieber V. Biosynthesis ‘debugged': novel bioproduction strategies. Eng. Life Sci. 13, 4–18 (2013). [Google Scholar]
  11. Billerbeck S., Härle J. & Panke S. The good of two worlds: increasing complexity in cell-free systems. Curr. Opin. Biotechnol. 24, 1037–1043 (2013). [DOI] [PubMed] [Google Scholar]
  12. Swartz J. R. Transforming biochemical engineering with cell-free biology. AIChE J. 58, 5–13 (2012). [Google Scholar]
  13. Rollin J. A., Tam T. K. & Zhang Y. H. P. New biotechnology paradigm: cell-free biosystems for biomanufacturing. Green Chem. 15, 1708–1719 (2013). [Google Scholar]
  14. Dudley Q. M., Karim A. S. & Jewett M. C. Cell-free metabolic engineering: biomanufacturing beyond the cell. Biotechnol. J. 10, 69–82 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chenault H. K., Simon E. S. & Whitesides G. M. Cofactor regeneration for enzyme-catalysed synthesis. Biotechnol. Genet. Eng. Rev. 6, 221–270 (1988). [DOI] [PubMed] [Google Scholar]
  16. Härle J. & Panke S. Synthetic biology for oligosaccharide production. Curr. Org. Chem. 18, 987–1004 (2014). [Google Scholar]
  17. Fessner W.-D. Systems biocatalysis: development and engineering of cell-free ‘artificial metabolisms' for preparative multienzymatic synthesis. New Biotechnol. 32, 658–664 (2015). [DOI] [PubMed] [Google Scholar]
  18. Dean S. M., Greenberg W. A. & Wong C. H. Recent advances in aldolase-catalyzed asymmetric synthesis. Adv. Synth. Catal. 349, 1308–1320 (2007). [Google Scholar]
  19. Endo T. & Koizumi S. Microbial conversion with cofactor regeneration using genetically engineered bacteria. Adv. Synth. Catal. 343, 521–526 (2001). [Google Scholar]
  20. Wagner N., Bosshart A., Failmezger J., Bechtold M. & Panke S. A separation-integrated cascade reaction to overcome thermodynamic limitations in rare sugar formation. Angew. Chem. Int. Ed. 54, 4182–4186 (2015). [DOI] [PubMed] [Google Scholar]
  21. Chen X. et al. Statistical experimental design guided optimization of a one-pot biphasic multienzyme total synthesis of amorpha-4, 11-diene. PLoS ONE 8, e79650 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schrittwieser J. H. et al. Deracemization by simultaneous bio-oxidative kinetic resolution and stereoinversion. Angew. Chem. Int. Ed. 53, 3731–3734 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Peters R. J. R. W. et al. Cascade reactions in multicompartmentalized polymersomes. Angew. Chem. Int. Ed. 53, 146–150 (2014). [DOI] [PubMed] [Google Scholar]
  24. Sehl T. et al. Two steps in one pot: enzyme cascade for the synthesis of nor(pseudo)ephedrine from inexpensive starting materials. Angew. Chem. Int. Ed. 52, 6772–6775 (2013). [DOI] [PubMed] [Google Scholar]
  25. O'Reilly E. et al. A regio- and stereoselective ω-transaminase/monoamine oxidase cascade for the synthesis of chiral 2,5-disubstituted pyrrolidines. Angew. Chem. Int. Ed. 53, 2447–2450 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. May O., Nguyen P. T. & Arnold F. H. Inverting enantioselectivity by directed evolution of hydantoinase for improved production of L-methionine. Nat. Biotechnol. 18, 317–320 (2000). [DOI] [PubMed] [Google Scholar]
  27. Korman T. P. et al. A synthetic biochemistry system for the in vitro production of isoprene from glycolysis intermediates. Protein Sci. 23, 576–585 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rieckenberg F., Ardao I., Rujananon R. & Zeng A.-P. Cell-free synthesis of 1,3-propanediol from glycerol with a high yield. Eng. Life Sci. 14, 380–386 (2014). [Google Scholar]
  29. You C. et al. Enzymatic transformation of nonfood biomass to starch. Proc. Natl Acad. Sci. USA 110, 7182–7187 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Qi P., You C. & Zhang Y.-H. P. One-pot enzymatic conversion of sucrose to synthetic amylose by using enzyme cascades. ACS Catal. 4, 1311–1317 (2014). [Google Scholar]
  31. Han X. et al. Chemo-enzymatic synthesis of polyhydroxyalkanoate (PHA) incorporating 2-hydroxybutyrate by wild-type class I PHA synthase from Ralstonia eutropha. Appl. Microbiol. Biotechnol. 92, 509–517 (2011). [DOI] [PubMed] [Google Scholar]
  32. Jewett M. C., Calhoun K. A., Voloshin A., Wuu J. J. & Swartz J. R. An integrated cell-free metabolic platform for protein production and synthetic biology. Mol. Syst. Biol. 4, 220 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Khattak W. A. et al. Yeast cell-free enzyme system for bio-ethanol production at elevated temperatures. Process Biochem. 49, 357–364 (2014). [Google Scholar]
  34. Woodward J., Orr M., Cordray K. & Greenbaum E. Enzymatic production of biohydrogen. Nature 405, 1014–1015 (2000). [DOI] [PubMed] [Google Scholar]
  35. Martin del Campo J. S. et al. High-yield production of dihydrogen from xylose by using a synthetic enzyme cascade in a cell-free system. Angew. Chem. Int. Ed. 52, 4587–4590 (2013). [DOI] [PubMed] [Google Scholar]
  36. Zhu Z., Tam T. K., Sun F., You C. & Zhang Y.-H. P. A high-energy-density sugar biobattery based on a synthetic enzymatic pathway. Nat. Commun. 5, 3026 (2014). [DOI] [PubMed] [Google Scholar]
  37. Sokic-Lazic D., de Andrade A. R. & Minteer S. D. Utilization of enzyme cascades for complete oxidation of lactate in an enzymatic biofuel cell. Electrochim. Acta 56, 10772–10775 (2011). [Google Scholar]
  38. Bujara M., Schümperli M., Pellaux R., Heinemann M. & Panke S. Optimization of a blueprint for in vitro glycolysis by metabolic real-time analysis. Nat. Chem. Biol. 7, 271–277 (2011). [DOI] [PubMed] [Google Scholar]
  39. Bakker B. M., Michels P. A. M., Opperdoes F. R. & Westerhoff H. V. Glycolysis in bloodstream form Trypanosoma brucei can be understood in terms of the kinetics of the glycolytic enzymes. J. Biol. Chem. 272, 3207–3215 (1997). [DOI] [PubMed] [Google Scholar]
  40. Chassagnole C., Noisommit-Rizzi N., Schmid J. W., Mauch K. & Reuss M. Dynamic modeling of the central carbon metabolism of Escherichia coli. Biotechnol. Bioeng. 79, 53–73 (2002). [DOI] [PubMed] [Google Scholar]
  41. Semenov S. N. et al. Rational design of functional and tunable oscillating enzymatic networks. Nat. Chem. 7, 160–165 (2015). [DOI] [PubMed] [Google Scholar]
  42. Niederholtmeyer H., Stepanova V. & Maerkl S. J. Implementation of cell-free biological networks at steady state. Proc. Natl Acad. Sci. USA 110, 15985–15990 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Kim J. & Winfree E. Synthetic in vitro transcriptional oscillators. Mol. Syst. Biol. 7, 465 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Karzbrun E., Tayar A. M., Noireaux V. & Bar-Ziv R. H. Programmable on-chip DNA compartments as artificial cells. Science 345, 829–832 (2014). [DOI] [PubMed] [Google Scholar]
  45. Rollin J. A. et al. High-yield hydrogen production from biomass by in vitro metabolic engineering: mixed sugars coutilization and kinetic modeling. Proc. Natl Acad. Sci. USA 112, 4964–4969 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Schümperli M., Pellaux R. & Panke S. Chemcial and enzymatic routes to dihydroxyacetone phosphate. Appl. Microbiol. Biotechnol. 75, 33–45 (2007). [DOI] [PubMed] [Google Scholar]
  47. Arkin A., Shen P. & Ross J. A test case of correlation metric construction of a reaction pathway from measurements. Science 277, 1275–1279 (1997). [Google Scholar]
  48. Maitra P. K. A glucokinase from Saccharomyces cerevisiae. J. Biol. Chem. 245, 2423–2431 (1970). [PubMed] [Google Scholar]
  49. Schomburg I. et al. BRENDA: a resource for enzyme data and metabolic information. Trends Biochem. Sci. 27, 54–56 (2002). [DOI] [PubMed] [Google Scholar]
  50. Schmidt H. & Jirstrand M. Systems Biology Toolbox for MATLAB: a computational platform for research in systems biology. Bioinformatics 22, 514–515 (2006). [DOI] [PubMed] [Google Scholar]
  51. Hindmarsh A. C. et al. SUNDIALS: suite of nonlinear and differential/algebraic equation solvers. ACM Transact. Math. Software 31, 363–396 (2005). [Google Scholar]
  52. Flamholz A., Noor E., Bar-Even A. & Milo R. eQuilibrator-the biochemical thermodynamics calculator. Nucleic Acids Res. 40, D770–D775 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Müller C. L. & Sbalzarini I. F. in EvoApplications 2010, Part 1 eds DiChic C.et al. 432–441Springer (2010). [Google Scholar]
  54. Hold C., Billerbeck S. & Panke S. Reaction model and experimental data. ETH Data Archive http://doi.org/10.5905/ethz-1007-60 (2016).

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Information

Supplementary Figures 1-13, Supplementary Tables 1-24, Supplementary Note 1, Supplementary Methods and Supplementary References.

ncomms12971-s1.pdf (2.5MB, pdf)
Peer Review File
ncomms12971-s2.pdf (285.2KB, pdf)

Data Availability Statement

Data supporting the findings of this study are available within the article (and its supplementary information files) and from the corresponding author on reasonable request. Also, the MATLAB model and all concentration data are available in the ETH Data Archive with the identifier IE2151530 (ref. 54).

Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES